Key Events This Week
7 Sep: Stock opens strong at Rs.129.15 (+2.87%) amid Sensex decline
10 Sep: New 52-week high of Rs.142.05 reached
10 Sep: Valuation shifts from attractive to fair amid price gains
11 Sep: Week closes at Rs.138.95 (+1.68%) with sustained volume

Broad-Based Technical Strength Lifts Zim Laboratories Ltd to 52-Week High of Rs 142.05
2026-09-10 09:53:01Surging to a fresh 52-week high of Rs 142.05 on 10 Sep 2026, Zim Laboratories Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market despite a subdued Sensex environment.
Read full news article
Zim Laboratories Ltd Valuation Shifts: From Attractive to Fair Amidst Strong Price Gains
2026-09-10 08:00:59Zim Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair rating. Despite this moderation in valuation appeal, the stock has demonstrated robust price performance year-to-date, significantly outperforming the broader Sensex index.
Read full news articleZim Laboratories Gains 0.44%: 4 Key Factors Driving the Week’s Volatility
2026-09-05 14:00:06
Key Events This Week
31 Aug: Stock opens at Rs.123.65, down 1.08%
1 Sep: Technical momentum shifts amid mixed signals, stock falls 3.84%
2 Sep: New 52-week high at Rs.135.8, stock surges 12.36%
3 Sep: Bullish momentum confirmed with technical upgrades, stock closes at Rs.133.60
4 Sep: Valuation shifts signal renewed attractiveness despite price dip

Zim Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness
2026-09-04 08:01:06Zim Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from a previously fair valuation to an attractive one. Despite a recent day decline of 4.23%, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a renewed price attractiveness relative to its historical levels and peer group, offering investors a fresh perspective on its market positioning.
Read full news article
Zim Laboratories Ltd is Rated Sell by MarketsMOJO
2026-09-03 10:10:33Zim Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 September 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article
Zim Laboratories Ltd Sees Bullish Momentum Amid Technical Upgrades
2026-09-03 08:05:01Zim Laboratories Ltd has demonstrated a significant shift in price momentum, supported by a series of technical indicator upgrades that suggest a bullish outlook. The stock’s recent surge, with a day change of 12.36%, reflects renewed investor interest amid improving technical signals, positioning it as a noteworthy contender in the Pharmaceuticals & Biotechnology sector.
Read full news article
Broad-Based Technical Strength Lifts Zim Laboratories Ltd to 52-Week High of Rs 135.8
2026-09-02 13:05:15Surging past its previous peaks, Zim Laboratories Ltd touched a fresh 52-week high of Rs 135.8 on 2 Sep 2026, marking a remarkable 73.03% gain over the past year despite a broadly declining Sensex. This milestone underscores the stock’s strong price momentum and technical resilience amid a volatile market backdrop.
Read full news articleAnnouncement under Regulation 30 (LODR)-Updates on Acquisition
15-Sep-2026 | Source : BSEUpdate on completion of investment in the share capitalof ZIM Scientific Office L.L.C. (Step Down Subsidiary) by ZIM Laboratories Limited FZE wholly owned subsidiary
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
12-Aug-2026 | Source : BSETranscript of Q1 FY27 Earning Conference call
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
12-Aug-2026 | Source : BSEPlease find enclosed the Scrutinizers Report and Voting Results of Postal Ballot.
Corporate Actions
No Upcoming Board Meetings
Zim Laboratories Ltd has declared 5% dividend, ex-date: 19 Sep 19
No Splits history available
Zim Laboratories Ltd has announced 2:1 bonus issue, ex-date: 22 Dec 22
No Rights history available







